Figure 3. HNF-6 is required for proper morphology of the neuromuscular junction.
Image credit: Audouard, et.al. 2012 under CC BY license

Funding Opportunities

To submit any new grant opportunities for this list, please email [email protected]. List the sponsor name, amount, due date, and contact information.

 


 

Current Funding Opportunities:


NEW! Imaging Scientists Initiative
Sponsor: Chan Zuckerberg Initiative
Description: The Chan Zuckerberg Initiative (CZI) seeks to support up to 10 Imaging Scientists who will work at the interface of biology, microscopy hardware, and imaging software at imaging centers across the United States. “Imaging Scientists” might be engineers, physicists, mathematicians, computer scientists, or biologists who have focused on technology development in either microscopy or data analysis fields. Each grant will fund salary and fringe benefits for an Imaging Scientist at the center, a modest travel and teaching budget, plus 15% indirect costs. The award period is three years plus, if renewed, an additional two years.
Deadline: Pre-Proposal due by October 3, 2018.



NEW! MRC AstraZeneca Centre for Lead Discovery Initiative
Sponsor: MRC and AstraZeneca
Description: The MRC/AstraZeneca Centre for Lead Discovery (CLD) aims to support academic UK-based researchers in discovering potential starting points for small molecule therapeutic approaches with a clear line-of-sight to therapeutic use. Awardees will benefit from unprecedented access to over two million molecules in AstraZeneca’s compound library, as well as its state-of-the-art high throughput screening facilities. Following completion of the HTS campaign, sufficient ‘hit’ data should be available to enable applicants to seek follow-on funding internally through confidence in concept or through the MRC’s Development Pathway Funding Scheme (DPFS).
Deadline: Application due by October 3, 2018.



NEW! MRC UCB Antibody Discovery Initiative
Sponsor: MRC and UCB
Description: This initiative aims to support academic researchers in the UK seeking to develop antibody-based therapeutics. It is intended to accelerate the transition from discovery research to translational development projects by enabling generation of novel antibodies suitable for testing in models of disease. A clear line-of-sight to therapeutic use will be required to secure funding.
Deadline: Application due by October 3, 2018.



Systems Approaches for the Discovery of Combinatorial Therapies for Complex Disorders
Sponsor: EU (Horizon 2020)
Deadline: Application due by October 2, 2018.



NEW! Discovering New Therapeutic Uses for Existing Molecules
Sponsor: NIH (NCATS)
Description: The National Center for Advancing Translational Sciences (NCATS) invites pre-applications for projects that test new therapeutic uses for experimental drugs or biologics across a broad range of human diseases. Strong applications will include scientific evidence that modulation of the target of the experimental therapy will have a positive impact on the disease/condition.
Deadline: Letter of Intent due by October 1, 2018.



Research Grants
Sponsor: Whitehall Foundation
Description: Funding is available for basic research in neurobiology.  Research grants of up to three years will be provided.  Grants for early career and established scientists are available.  A renewal grant with a maximum of two years is possible, but it will be awarded on a competitive basis.  Research grants normally range from $30,000 to $75,000 per year.
Deadline: Letter of Intent due by October 1, 2018.



Canada Gairdner International Awards
Sponsor: Canada Gairdner Foundation
Description: This award recognizes outstanding biomedical scientists who have made original contributions to medicine with the goal of contributing through research to increased understanding of human biology and disease. Nominees should be individuals whose seminal discoveries and major scientific contributions constitute an original and significant achievement in biomedical science. The award is $100,000 CAD.
Deadline: Application due by October 1, 2018.



Career Award for Medical Scientists
Sponsor: Burroughs Wellcome Fund
Description: The Career Awards for Medical Scientists (CAMS) is a highly competitive program that provides $700,000 awards over five years for physician-scientists, who are committed to an academic career, to bridge advanced postdoctoral/fellowship training and the early years of faculty service. Proposals must be in the area of basic biomedical, disease-oriented, or translational research.  


Deadline: Application due by October 1, 2018.



Warren Alpert Scholars – Fellowship Award (Neuroscience)
Sponsor: Warren Alpert Foundation
Description: This award will support individual scientists of exceptional creativity who have an MD or PhD degree and who have completed three years of post-doctoral fellowship in a medical school in the basic neurosciences. These awards are given as transitional post-doctoral awards for recipients before they later become a full time faculty member at the Assistant Professor level or higher. The Scholars will be awarded $200,000 annually for two years to cover their salary, lab costs, and related expenses.
Deadline: Application due by January 15, 2019.



New Investigator Research Grant, Neuroscience and Mental Health
Sponsor: MRC
Description: This funding program aims to support individuals seeking to transition to independence through their first grant as a Principal Investigator.
Deadline: Application due by October 3, 2018.



Excellent Paper In Neuroscience Award
Sponsor: Network of European Funding for Neuroscience Research (ERA Net Neuron)
Description: The ERA-NET NEURON partner countries are issuing the EXCELLENT PAPER IN NEUROSCIENCE AWARD to recognize the most remarkable and outstanding scientific publications by young researchers in the field of disease-related neurosciences. First authors of candidate publications published between January 1, 2017 and December 31, 2017 and affiliated with the call partner countries are eligible to apply. The award is 3,000 Euros.
Deadline: Application due by October 1, 2018.



Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases
Sponsor: NIH
Description: This funding opportunity announcement aims to promote innovative research across multiple disciplines to increase knowledge of understudied non-olfactory G protein-coupled receptors, ion channels, and protein kinases. The submission of small research (R03) applications is encouraged from institutions and organizations proposing projects leading to a better understanding of eligible proteins identified as understudied by the Common Fund Program "Illuminating the Druggable Genome."
Deadline: Letter of Intent due by September 26, 2018.



Clinical Research Training Scholarship in ALS
Sponsor: ALS Association and American Brain Foundation
Description: This award aims to encourage young investigators to pursue clinical studies in ALS. The award will consist of a commitment of $65,000 per year for two years, plus a $10,000 per year stipend to support education and research-related costs for a total of $150,000. Supplementation of the award with other grants is permissible, but to be eligible to apply for this award, the other grant source(s) cannot exceed $75,000 annually.
Deadline: Application due by October 1, 2018.



Richard Olney Clinician Scientist Development Award in ALS
Sponsor: ALS Association, American Brain Foundation
Description: This award aims to encourage young investigators to pursue clinical studies in ALS. A commitment of $75,000 per year for three years, plus a $5,000 per year stipend to support education and research-related costs for a total of $240,000. Supplementation of the award with other grants is permissible, but to be eligible to apply for this award, the other grant source(s) cannot exceed $80,000 annually.
Deadline: Application due by October 1, 2018.



Sartorius & Science Prize for Regenerative Medicine & Cell Therapy
Sponsor: Science and The Sartorius Group
Description: The Sartorius & Science Prize for Regenerative Medicine & Cell Therapy is an annual prize geared toward researchers focused on basic or translational research that advances regenerative medicine and cell therapy; for example cell-, gene-, or immunotherapy, tissue engineering, and materials engineering. The winner is awarded US$25,000 and publication of his or her essay in Science.
Deadline: Application due by October 1, 2018.



Clinical Neuroscience Research Grants
Sponsor: Dana Foundation
Description: This grant funds "first-in-man" clinical studies of therapies being developed for brain diseases. Funded studies can receive up to $300,000 payable over three years. Potential applicants may submit a preliminary proposal and budget to determine full proposal eligibility. Applications are not solely restricted to clinical research scientists based in the United States.
Deadline: Applications are accepted on a rolling basis.



Early Phase Clinical Trials, Canada (Includes FTD)
Sponsor: Weston Brain Institute
Description: The Early Phase Clinical Trials Canada program provides funding to support clinical trials and/or clinical trial sub-studies that could accelerate the development of therapeutics for neurodegenerative disease aging, including FTD. Eligible principal investigators must be at or above the level of Assistant Professor or equivalent, and be affiliated with a CRA-qualified institution located in Canada. A maximum of $1,500,000 per project over up to 4 years.
Deadline: Applications will be accepted on a rolling basis.



Catalyst Grant: New Genes for Rare Diseases
Sponsor: Rare Diseases Models and Mechanisms Network
Description: On behalf of the Clinical Advisory Committee of the Rare Diseases: Models and Mechanisms Network, the Co-Chairs would like to invite applications from clinicians and clinician scientists who have discovered novel genes in patients with rare diseases and wish to collaborate with a model organism investigator who is able to carry out functional analysis on an orthologous gene in a model system. A maximum of $25,000 CAD will be awarded. Applications may be submitted by any investigator associated with a Canadian Institution.
Deadline: Applications will be accepted on a rolling basis.



NIH Scored Unfunded Grants (includes FTD)
Sponsor: Alzheimer's Drug Discovery Foundation
Description: This request for proposals supports NIA and NINDS grant proposals in NIH format that were scored but not funded, which fall within our mission and research priorities. This includes frontotemporal dementias.
Deadline: Applications are accepted on a rolling basis.



Biomedical Research Project Grants
Sponsor: Motor Neurone Disease Association
Description: The MND Association supports biomedical research on ALS and related conditions, in all relevant disciplines. The objectives of the MND Association research funding programme are to support research aimed at understanding the causes of MND, elucidating disease mechanisms and facilitating the translation of therapeutic strategies from the laboratory to the clinic. Applications will begin to be accepted on September 7, 2018. Researchers outside the UK are eligible to apply if the project is unique in concept or design (i.e. not being performed in the UK) or the project involves a significant collaboration with a UK institute. Applications for project grants should not exceed £85,000 per annum (and £255,000 in total) without the prior agreement of the MND Association.
Deadline: Application due by November 2, 2018.



Frick Foundation for ALS Research Award
Sponsor: Bruno and Ilse Frick Foundation for Research on ALS
Description: The aim of the Foundation is to encourage basic biomedical research related to understanding the cause of ALS. The funding is 100,000 CHF over 2 years.
Deadline: Application due by October 8, 2018.



NINDS Training and Career Development Awards
Sponsor: NIH National Institute of Neurological Disorders and Stroke (NINDS)
Description: NINDS offers a wide range of training and career development funding opportunities including pre-doctoral fellowships, post-doctoral fellowships, mentored career development awards, institutional programs, independent scientists awards, clinical research awards and more. All programs are open to researchers focusing on the study of ALS and related conditions.
Deadline: Varies, see individual program for details.



NeuroNEXT Infrastructure Resource Access
Sponsor: NIH National Institute of Neurological Disorders and Stroke (NINDS)
Description:

This funding opportunity announcement (FOA) encourages proposals for biomarker validation trials or exploratory clinical trials of drugs, biologics, surgical therapies or devices that may contribute to the justification for and provide the data required to design a future trial to confirm efficacy (i.e., a Phase III trial) in the treatment of neurologic disease. Proposals for drugs or biologics should provide compelling scientific evidence that the investigational agent proposed for study will reach/act upon the designated target or that its mechanism of action is such that it will be of benefit in ameliorating a specific aspect of the disease.

Diseases chosen for study should be based on the NINDS' strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm). Successful applicants will be given access to the NeuroNEXT infrastructure. The NeuroNEXT Clinical Coordinating Center (CCC) will work with the successful applicant to efficiently implement the proposed study. The NeuroNEXT Data Coordinating Center (DCC) will provide statistical and data management support. The NeuroNEXT clinical sites will provide recruitment/retention support as well as on-site implementation of the clinical protocol.


Deadline: Applications are accepted on a rolling basis.



CLIN 3: Partnering Opportunity for Stem Cell Therapy Registration Clinical Trials
Sponsor: California Institute of Regenerative Medicine (CIRM)
Description: The objective of this program announcement is to support new activities on active CIRM-funded clinical trial projects that will directly enable product registration with the Food and Drug Administration (FDA). This award is only available to holders of a current CLIN2 award for a trial that has been deemed by FDA to be sufficient for registration.
Deadline: Applications due by 2PM PST on the the last business day of each month.



CLIN 2: Partnering Opportunity for Clinical Trial Stage Projects
Sponsor: California Institute of Regenerative Medicine (CIRM)
Description: The objective of this program announcement is to create a highly competitive partnering opportunity to accelerate the completion of a clinical trial for a promising stem or progenitor cell-based treatment that addresses an unmet medical need. The maximum award is $10-15M USD.
Deadline: Applications due by 2PM PST on the last business day of each month.



CLIN 1: Partnering Opportunity for Late Stage Preclinical Projects
Sponsor: California Institute of Regenerative Medicine (CIRM)
Description: The objective of this program announcement is to create a highly competitive partnering opportunity to accelerate the completion an IND or IDE filing with the FDA and initiate clinical trial start-up with a promising stem or progenitor cell-based treatment that addresses an unmet medical need. The maximum award is $6M USD. CIRM expects projects under this program to advance rapidly into the clinic and to achieve the proposed IND filing within 18 months.
Deadline: Applications due by 2PM PST on the last business day of each month.



NIH TRND Program and NIH BrIDGs Program
Sponsor: NIH National Center for Advancing Translational Sciences (NCATS)
Description: NCATS is now accepting proposals on a rolling basis to collaborate with Bridging Interventional Development Gaps (BrIDGs) and Therapeutics for Rare and Neglected Diseases (TRND) program scientists. Click here to apply.
Deadline: Now accepting rolling applications.



DISC 2: The Quest Awards (Stem Cells)
Sponsor: California Institute for Regenerative Medicine (CIRM)
Description: This award program promotes the discovery of promising new stem cell-based technologies that could be translated to enable broad use and ultimately, improve patient care. Projects funded through the Quest Awards should propose technology that is uniquely enabled by human stem/progenitor cells or directly reprogrammed cells, or uniquely enabling for the advancement of stem cell-based therapies. Up to $500,000 USD will be awarded to achieve a candidate that is a diagnostic, a medical device or a tool; or up to $900,000 USD per award to achieve a candidate that is a therapeutic.
Deadline: TBD.



Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail